
I lost 6 stone on Mounjaro and here's 6 things I wish I'd known before starting – a 5p drink is essential for the nausea
NO WEIGH! I lost 6 stone on Mounjaro and here's 6 things I wish I'd known before starting – a 5p drink is essential for the nausea
A WOMAN who lost six stone after taking weight loss jab Mounjaro has revealed the six things she wishes she knew before starting and says a 5p drink made all the difference.
Lucy Davies, who shares her journey on TikTok under the name @InsightfulLucy, has been documenting her dramatic transformation after starting the popular weight-loss injection.
2
Lucy Davies lost 6 stones on Mounjaro
Credit: SWNS
2
She shared her dramatic weight loss journey with followers on Tiktok
Credit: SWNS
Lucy turned to Mounjaro, a jab that's part of a new generation of weight-loss meds, to help her slim down.
It's similar to Ozempic, but packs an even bigger punch when it comes to appetite control.
The results were no doubt impressive but Lucy insists there's plenty people don't tell you before starting.
Now feeling lighter, healthier and more confident, she's spilling the tea, quite literally, on the real-life hacks that helped her through it.
Here are Lucy's top tips for new users.
Her number one survival tool was a mug of peppermint tea.
The herbal brew, which costs just 5p a bag in some shops, became her go-to remedy for the queasy side effects that came with the jab.
She swears it was the only thing that settled her stomach when the nausea hit.
She also learned the hard way that fizzy drinks are a no-go.
Even one can left her feeling bloated and sick.
I've lost nearly 6 stone in 9 months on fat jabs - trolls call me 'lazy' & say it's the 'easy way out' but I don't care
'It just wasn't worth it,' she says, and warns others to give the bubbles a miss unless they fancy an upset stomach.
Hydration, too, played a big part in her transformation.
While most users are told to aim for two litres of water a day, Lucy pushed that up to three and says the benefits were obvious.
More energy, fewer headaches, and a much easier ride through the jab's side effects.
But while Mounjaro helps shrink your appetite, Lucy warns that doesn't mean you can skip meals.
One mistake she made early on was not eating enough and it left her wiped out.
She recommends tracking your calories, not to diet harder, but to make sure your body's still getting the fuel it needs to function properly.
Another crucial tip is not to fall for the idea that this jab is some kind of magic wand.
Fellow user Kathryn, who's dropped three stone herself, says "Mounjaro is a tool, not a miracle. You still need to put the work in".
That means eating better, moving more, and listening to your body.
Not every vitamin under the sun will help, either.
It's about finding what works for you and not overloading your system with unnecessary supplements.
One thing Kathryn says is often overlooked was fibre.
While everyone's banging on about protein, she found getting enough fibre made a huge difference, keeping her digestion in check and helping her feel fuller for longer.
A common misconception among jab users is that they shouldn't feel any hunger at all while taking them.
This can lead to unnecessary concerns about whether their current dose is working, especially when they're taking lower doses.
One of the ways GLP-1 medications like Mounjaro work is by calming
hunger signals in the brain, helping patients feel satisfied with smaller portions.
But they do not and should not eliminate hunger
altogether.
Kiran Jones, clinical pharmacist at Oxford Online Pharmacy, said: "Hunger is the body's way of signalling it needs fuel, and
even patients on higher doses like 12.5mg or 15mg should feel hunger
at times."
He added: 'People think these medicines switch off hunger completely, but that's not how they work.
"Being able to eat is normal. Success looks different for everyone, and often, the biggest wins are quiet ones: more energy, less breathlessness, and better sleep.
'Becoming healthier without extreme diets or private clinics is a powerful example of what good, regulated care can achieve.
"Patients need safety, not pressure.'

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Guardian
2 hours ago
- The Guardian
Demand for weight loss drugs is becoming unsustainable, say pharmacists
Demand for weight loss drugs is becoming so 'unsustainable' that demand may soon outstrip supply, pharmacists have warned. The National Pharmacy Association (NPA) said supply problems could encourage people to turn to unregulated online sources, despite the risks involved. The number of people in the UK using drugs such as Wegovy and Mounjaro has soared to well above a million, with most patients paying to get them privately. During April, 1.6m packs of Mounjaro and Wegovy were bought in Britain, with the number thought to correlate closely with the number of people using them. 'Spiralling demand for weight loss medication risks going far beyond what is clinically deliverable', the NPA said. The drugs might need to be reserved for those in greatest need because they are so overweight instead of being given to the 'worried well', it added. New polling has found that 21% of Britons have tried to get hold of the medications over the past year, a figure that rises to 35% among 18- to 34-year-olds. The same survey found that 41% of all age groups would use them if they were free on the NHS. This figure rose to 64% among those aged 25-34. Savanta interviewed a representative sample of 2,002 adults aged 18 or over online from 20-23 June for the NPA, which represents 6,000 independent pharmacies. 'Weight loss jabs are one of the biggest drug innovations this century but growing demand for weight loss treatment highlights the need to make sure this is appropriate for those who want it,' said Olivier Picard, the NPA's chair. 'It's clear from this polling that more people are interested in getting weight loss jabs than can benefit from weight loss medication.' Supply of the medicines has been hit by shortages in some parts of the UK, including for higher doses of Mounjaro, the NPA said. Supply has been restricted to some pharmacies, which has stopped some new patients from going on to the drugs. The Medicines and Healthcare products Regulatory Agency, the UK's drugs watchdog, has warned patients to obtain the drugs only with a doctor's prescription, and not from beauty parlours or websites. A Department of Health spokesperson said more people would be able to obtain 'revolutionary' weight loss jabs over the next few years. 'Weight loss drugs are a powerful tool in tackling the obesity crisis head-on as part of our 10-year health plan', they added. 'This government is committed to ensuring that more people have access to these revolutionary drugs when needed, and crucially that they are able to do so in a safe and controlled way. We will ensure that those most in need will receive treatment first.' About 220,000 people in England are due to be offered tirzepatide, a diabetes drug that promotes weight loss, over the next three years. Pharmacies already provide about 85% of all weight loss drugs and need to be closely involved in the expansion of access, Picard added. 'The government should use the massive untapped expertise and skills of pharmacists to help speed up the NHS's weight loss medication programme to millions of the most in need patients,' he said.


South Wales Guardian
3 hours ago
- South Wales Guardian
Pharmacies warn of unsustainable demand for weight loss medication
Many more patients are interested in using weight loss medication than are actually suitable for treatment, according to the National Pharmacy Association (NPA), which represents more than 6,000 independent community pharmacies. Some 21% of people who were interviewed in a NPA-commissioned poll agreed they had attempted to access weight loss treatments in the last year, either online or in person at a pharmacy, rising to 35% of 16 to 34-year-olds. This is compared to only 7% of those over 55. There were also 41% who agreed they would opt for weight loss treatments on the NHS if they were made available to them. This figure rose to 64% among 25 to 34-year-olds, despite many of these patients being unlikely to be clinically eligible. The NPA says the poll, in which 2,002 people were interviewed, reflects an increasing demand for private and NHS weight loss services. NPA chairman Olivier Picard said: 'Weight loss jabs are one of the biggest drug innovations this century, but growing demand for weight loss treatment highlights the need to make sure this is appropriate for those who want it. 'It's clear from this polling that many more people are interested in getting weight loss jabs than would actually be suitable for treatment. 'We want to make sure supplies are carefully managed so that those in most clinical need can benefit from weight loss medication.' Spiralling demand, fuelled partly by social media, could see people being tempted to resort to unregulated online suppliers instead of regulated pharmacies staffed by medical professionals, they fear. Online suppliers may not be offering weight loss jabs alongside a structured programme aimed at helping them change their behaviour. Wegovy and Mounjaro are among a number of drugs that are recommended to help tackle obesity on the NHS. Mounjaro and Wegovy are licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) for use in patients with a BMI of over 30 or between 27 and 30 but with a weight-related co-morbidity. This occurs when an individual who has obesity develops another medical condition due to their weight. The NHS currently rolls out Mounjaro to patients with a BMI of over 40 and at least four co-morbidities, the NPA says. The NPA is calling for new regulations to protect patients buying weight loss medication online, so there is a full two-way consultation and all relevant historical medical records are reviewed before the treatment is prescribed. They are waiting for more details about the role pharmacies could play in the rollout of the NHS weight management programme. At least 85% of weight loss medication prescriptions were made by pharmacies in April this year, the NPA estimates. Mr Picard said: 'Pharmacists are experts in medication and many have extensive experience delivering weight loss injections as part of a package of care, including lifestyle advice. 'Pharmacies are well placed to help roll this treatment out on the NHS, and help people make the best use of these powerful medicines.'

Leader Live
3 hours ago
- Leader Live
Pharmacies warn of unsustainable demand for weight loss medication
Many more patients are interested in using weight loss medication than are actually suitable for treatment, according to the National Pharmacy Association (NPA), which represents more than 6,000 independent community pharmacies. Some 21% of people who were interviewed in a NPA-commissioned poll agreed they had attempted to access weight loss treatments in the last year, either online or in person at a pharmacy, rising to 35% of 16 to 34-year-olds. This is compared to only 7% of those over 55. There were also 41% who agreed they would opt for weight loss treatments on the NHS if they were made available to them. This figure rose to 64% among 25 to 34-year-olds, despite many of these patients being unlikely to be clinically eligible. The NPA says the poll, in which 2,002 people were interviewed, reflects an increasing demand for private and NHS weight loss services. NPA chairman Olivier Picard said: 'Weight loss jabs are one of the biggest drug innovations this century, but growing demand for weight loss treatment highlights the need to make sure this is appropriate for those who want it. 'It's clear from this polling that many more people are interested in getting weight loss jabs than would actually be suitable for treatment. 'We want to make sure supplies are carefully managed so that those in most clinical need can benefit from weight loss medication.' Spiralling demand, fuelled partly by social media, could see people being tempted to resort to unregulated online suppliers instead of regulated pharmacies staffed by medical professionals, they fear. Online suppliers may not be offering weight loss jabs alongside a structured programme aimed at helping them change their behaviour. Wegovy and Mounjaro are among a number of drugs that are recommended to help tackle obesity on the NHS. Mounjaro and Wegovy are licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) for use in patients with a BMI of over 30 or between 27 and 30 but with a weight-related co-morbidity. This occurs when an individual who has obesity develops another medical condition due to their weight. The NHS currently rolls out Mounjaro to patients with a BMI of over 40 and at least four co-morbidities, the NPA says. The NPA is calling for new regulations to protect patients buying weight loss medication online, so there is a full two-way consultation and all relevant historical medical records are reviewed before the treatment is prescribed. They are waiting for more details about the role pharmacies could play in the rollout of the NHS weight management programme. At least 85% of weight loss medication prescriptions were made by pharmacies in April this year, the NPA estimates. Mr Picard said: 'Pharmacists are experts in medication and many have extensive experience delivering weight loss injections as part of a package of care, including lifestyle advice. 'Pharmacies are well placed to help roll this treatment out on the NHS, and help people make the best use of these powerful medicines.'